Decreased Ceftriaxone Susceptibility in Emerging (35B and 6C) and Persisting (19A) Streptococcus pneumoniae Serotypes in the United States, 2011-2012: Ceftaroline Remains Active In Vitro among β-Lactam Agents

Eitemau Tebyg

• Activity of Ceftaroline against Recent Emerging Serotypes of Streptococcus pneumoniae in the United States
  gan: Jacobs, Michael R., et al.
  Cyhoeddwyd: (2010)
• Antimicrobial Activity of Ceftaroline-Avibactam Tested against Clinical Isolates Collected from U.S. Medical Centers in 2010-2011
  gan: Sader, Helio S., et al.
  Cyhoeddwyd: (2013)
• Noninvasive Streptococcus pneumoniae Serotypes Recovered from Hospitalized Adult Patients in the United States in 2009 to 2012
  gan: Mendes, Rodrigo E., et al.
  Cyhoeddwyd: (2015)
• Antimicrobial Activity of Ceftaroline Tested against Staphylococci with Reduced Susceptibility to Linezolid, Daptomycin, or Vancomycin from U.S. Hospitals, 2008 to 2011
  gan: Sader, Helio S., et al.
  Cyhoeddwyd: (2013)
• Baseline Activity of Telavancin against Gram-Positive Clinical Isolates Responsible for Documented Infections in U.S. Hospitals (2011-2012) as Determined by the Revised Susceptibility Testing Method
  gan: Mendes, Rodrigo E., et al.
  Cyhoeddwyd: (2014)